Bezaitbrate attenuates the increase in blood pressure in fructose-fed rats

Xiaochen Si, Joyce M. Richey, R Clinton Webb

Research output: Contribution to journalArticle

Abstract

A high fructose diet induces hypertension (HTN). insulin resistance (InsR), and hypertriglyceridemia (HTG). The sequence of these metabolic abnormalities associated with this dietary regimen remains to be elucidated. We hypothesize that HTG leads tds to the development of HTN and InsR in the fructose-fed animal model. Thus, we evaluated the effects of the lipid-lowering drug bezafibrate (BZFB) on FRU-induced HTN and InsR. Male Sprague Dawley rats were divided into 4 groups and placed on the following diets for five weeks; 60% FRU (n=5). FRU+BZFB (30 mg/kg/days (n=5); regular chow (C) (n=6), and regular chow + BZFB (C+BZFB)) (n=6). The results are summarized below. Groups Blood Pressure (mmHg) Triglyceride (mg/dl) FRU (n=5) 144.4 ± 10 * 130.4 ± 18.* 2 FRU+BZFB (n=S) 126 ± 5 102 ± 37# CB (n=6) 125.5 ± 6 76 ± 45 C (n=6) 125.5 ± 8 54 ± 21 (Blood Pressure: * P<0.05 FRU vs. other three groups; Triglyceride: * P<0.05 FRU vs. CB, 2 P<0.01 FRU vs. C; # P<0.05 FRU+BZFB vs. CB.) Bezafibrate treatment was effective in preventing the elevation in blood pressure associated with fructose feeding. We conclude that HTG is a contributing factor in the development of HTN in the FRU-fed animal model.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - Dec 1 1997
Externally publishedYes

Fingerprint

Bezafibrate
Blood pressure
Fructose
hypertriglyceridemia
hypertension
blood pressure
Rats
fructose
insulin resistance
Blood Pressure
Hypertriglyceridemia
rats
Hypertension
Insulin Resistance
animal models
triacylglycerols
lipemic effect
Insulin
Nutrition
Animals

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Bezaitbrate attenuates the increase in blood pressure in fructose-fed rats. / Si, Xiaochen; Richey, Joyce M.; Webb, R Clinton.

In: FASEB Journal, Vol. 11, No. 3, 01.12.1997.

Research output: Contribution to journalArticle

@article{73d0be98b79e4c9b99a262cee1658b77,
title = "Bezaitbrate attenuates the increase in blood pressure in fructose-fed rats",
abstract = "A high fructose diet induces hypertension (HTN). insulin resistance (InsR), and hypertriglyceridemia (HTG). The sequence of these metabolic abnormalities associated with this dietary regimen remains to be elucidated. We hypothesize that HTG leads tds to the development of HTN and InsR in the fructose-fed animal model. Thus, we evaluated the effects of the lipid-lowering drug bezafibrate (BZFB) on FRU-induced HTN and InsR. Male Sprague Dawley rats were divided into 4 groups and placed on the following diets for five weeks; 60{\%} FRU (n=5). FRU+BZFB (30 mg/kg/days (n=5); regular chow (C) (n=6), and regular chow + BZFB (C+BZFB)) (n=6). The results are summarized below. Groups Blood Pressure (mmHg) Triglyceride (mg/dl) FRU (n=5) 144.4 ± 10 * 130.4 ± 18.* 2 FRU+BZFB (n=S) 126 ± 5 102 ± 37# CB (n=6) 125.5 ± 6 76 ± 45 C (n=6) 125.5 ± 8 54 ± 21 (Blood Pressure: * P<0.05 FRU vs. other three groups; Triglyceride: * P<0.05 FRU vs. CB, 2 P<0.01 FRU vs. C; # P<0.05 FRU+BZFB vs. CB.) Bezafibrate treatment was effective in preventing the elevation in blood pressure associated with fructose feeding. We conclude that HTG is a contributing factor in the development of HTN in the FRU-fed animal model.",
author = "Xiaochen Si and Richey, {Joyce M.} and Webb, {R Clinton}",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Bezaitbrate attenuates the increase in blood pressure in fructose-fed rats

AU - Si, Xiaochen

AU - Richey, Joyce M.

AU - Webb, R Clinton

PY - 1997/12/1

Y1 - 1997/12/1

N2 - A high fructose diet induces hypertension (HTN). insulin resistance (InsR), and hypertriglyceridemia (HTG). The sequence of these metabolic abnormalities associated with this dietary regimen remains to be elucidated. We hypothesize that HTG leads tds to the development of HTN and InsR in the fructose-fed animal model. Thus, we evaluated the effects of the lipid-lowering drug bezafibrate (BZFB) on FRU-induced HTN and InsR. Male Sprague Dawley rats were divided into 4 groups and placed on the following diets for five weeks; 60% FRU (n=5). FRU+BZFB (30 mg/kg/days (n=5); regular chow (C) (n=6), and regular chow + BZFB (C+BZFB)) (n=6). The results are summarized below. Groups Blood Pressure (mmHg) Triglyceride (mg/dl) FRU (n=5) 144.4 ± 10 * 130.4 ± 18.* 2 FRU+BZFB (n=S) 126 ± 5 102 ± 37# CB (n=6) 125.5 ± 6 76 ± 45 C (n=6) 125.5 ± 8 54 ± 21 (Blood Pressure: * P<0.05 FRU vs. other three groups; Triglyceride: * P<0.05 FRU vs. CB, 2 P<0.01 FRU vs. C; # P<0.05 FRU+BZFB vs. CB.) Bezafibrate treatment was effective in preventing the elevation in blood pressure associated with fructose feeding. We conclude that HTG is a contributing factor in the development of HTN in the FRU-fed animal model.

AB - A high fructose diet induces hypertension (HTN). insulin resistance (InsR), and hypertriglyceridemia (HTG). The sequence of these metabolic abnormalities associated with this dietary regimen remains to be elucidated. We hypothesize that HTG leads tds to the development of HTN and InsR in the fructose-fed animal model. Thus, we evaluated the effects of the lipid-lowering drug bezafibrate (BZFB) on FRU-induced HTN and InsR. Male Sprague Dawley rats were divided into 4 groups and placed on the following diets for five weeks; 60% FRU (n=5). FRU+BZFB (30 mg/kg/days (n=5); regular chow (C) (n=6), and regular chow + BZFB (C+BZFB)) (n=6). The results are summarized below. Groups Blood Pressure (mmHg) Triglyceride (mg/dl) FRU (n=5) 144.4 ± 10 * 130.4 ± 18.* 2 FRU+BZFB (n=S) 126 ± 5 102 ± 37# CB (n=6) 125.5 ± 6 76 ± 45 C (n=6) 125.5 ± 8 54 ± 21 (Blood Pressure: * P<0.05 FRU vs. other three groups; Triglyceride: * P<0.05 FRU vs. CB, 2 P<0.01 FRU vs. C; # P<0.05 FRU+BZFB vs. CB.) Bezafibrate treatment was effective in preventing the elevation in blood pressure associated with fructose feeding. We conclude that HTG is a contributing factor in the development of HTN in the FRU-fed animal model.

UR - http://www.scopus.com/inward/record.url?scp=33750228059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750228059&partnerID=8YFLogxK

M3 - Article

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -